CHU de Bordeaux
Bordeaux, 33000, France
NCT Number: NCT02217371
In a previous protocol, we highlighted an excessive daytime sleepiness at the Maintenance of Wakefulness Tests (MWT) in 36% of adult Attention Deficit Disorder with or without Hyperactivity (ADHD) patients. In 40% of cases this sleepiness was associated with a sleep disorder objectified by polysomnography (PSG): apnea hypopnea syndrome (AHI) ≥ 10/h and / or Periodicals Movements of Lower Limb (PLMI) ≥ 15/h. However, among patients with no sleep disorder PSG, we can question the central origin of the Excessive Daytime Sleepiness. Thus, we wish to determine potential changes in the regulation of sleep / wake cycle through a protocol of extended wake.
The principal objective is to compare the objective sleepiness in sleepy patients with ADHD and healthy subjects during a protocol of extended wake.
It's an observational study of interventional type realized in patient with ADHD syndrome deprived of psychostimulant treatment (for 72 hours) and healthy subject, investigating the implication of the homeostatic and circadian systems in the preservation of awakening.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Bordeaux, 33000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For ADHD patient:
For healthy subject:
Exclusion criteria
The tests are :
Go/NoGo paradigm, Continuous Performance Test (CPT) II , Wisconsin Card Sorting Test (WCST), virtual CPT, Classic and virtual Stroop, PSG, MWT
These tests will be repeated during 32h each 4h (T0h, T4h, T8h, T12h, T16h, T20h, T24h, T28h et T32h).
Time frame: at inclusion (day 0)
Comparison of objective sleepiness in sleepy patients with ADHD and healthy subjects during a protocol of extended wake.
Time frame: At inclusion (Day 0)
Time constant and asymptotic value of the spectral power of the theta-alpha band of EEG sleep
Time frame: At inclusion (day 0)
Time frame: At inclusion (day 0)
Time frame: At inclusion (day 0)
University Hospital, Bordeaux
Other
Acronym: VEILLETDAH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07633275
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Changsha, Hunan, China
View Trial DetailsNCT06185985
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
New York, United States
View Trial DetailsNCT01342445
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Bethlehem, Pennsylvania, United States
View Trial DetailsNCT05778526
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Hong Kong
View Trial Details